Israel Englander Pacific Biosciences Of California, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 198,200 shares of PACB stock, worth $362,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,200

Previous 150,000 32.13%

Holding current value

$362,706

Previous $205,000 63.9%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.2 - $2.17 $6.95 Million - $12.6 Million	5,792,951 Added 125.13%	10,422,578 $17.7 Million
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $3.01 Million - $8.09 Million	2,215,506 Added 91.77%	4,629,627 $6.34 Million
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $8.5 Million - $23.2 Million	2,414,121 New	2,414,121 $9.05 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $13 Million - $18.3 Million	1,303,381 New	1,303,381 $17.3 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $1.92 Million - $3.79 Million	338,261 Added 129.29%	599,888 $4.91 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $761,075 - $1.66 Million	193,658 Added 284.92%	261,627 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $9.52 Million - $24.7 Million	-2,368,933 Reduced 97.21%	67,969 $300,000
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $16.7 Million - $41.4 Million	1,978,498 Added 431.61%	2,436,902 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $1.33 Million - $2.08 Million	69,124 Added 17.76%	458,404 $9.38 Million
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $6.9 Million - $9.73 Million	-277,725 Reduced 41.64%	389,280 $9.95 Million
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $7.23 Million - $11.7 Million	324,372 Added 94.67%	667,005 $23.3 Million
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $29.9 Million - $58 Million	-1,132,951 Reduced 76.78%	342,633 $11.4 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $7.22 Million - $19.6 Million	-687,281 Reduced 31.78%	1,475,584 $38.3 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $459,921 - $1.26 Million	127,402 Added 6.26%	2,162,865 $21.3 Million
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $836,960 - $1.27 Million	-315,834 Reduced 13.43%	2,035,463 $7.02 Million
Q1 2020 May 14, 2020	SELL	$2.36 - $5.26 $446,731 - $995,681	-189,293 Reduced 7.45%	2,351,297 $7.2 Million
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $3 Million - $3.63 Million	651,690 Added 34.5%	2,540,590 $13.1 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $6.18 Million - $7.63 Million	1,239,200 Added 190.73%	1,888,900 $9.75 Million
Q2 2019 Aug 15, 2019	SELL	$5.92 - $7.41 $12.3 Million - $15.4 Million	-2,080,762 Reduced 76.21%	649,700 $3.93 Million
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $437,743 - $476,367	64,374 Added 2.41%	2,730,462 $19.7 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $9.35 Million - $18.3 Million	2,343,773 Added 727.17%	2,666,088 $19.7 Million
Q3 2018 Nov 14, 2018	SELL	$3.52 - $5.55 $77,014 - $121,428	-21,879 Reduced 6.36%	322,315 $1.74 Million
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $115,355 - $214,310	54,671 Added 18.88%	344,194 $1.22 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $335,722 - $528,967	163,767 Added 130.23%	289,523 $594,000
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $2.17 Million - $4.55 Million	-836,465 Reduced 86.93%	125,756 $332,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $3.08 Million - $5.36 Million	962,221	962,221 $5.05 Million

Others Institutions Holding PACB

# of Institutions

255

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $411M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account